Cryoablation
Total Payments
$252,905
Transactions
9
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $252,905 | 9 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $252,905 | 9 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Phase I/II Study of Dendritic Cell Therapy Delivered Intratumorally after Cryoablation & Anti- PD-1 Antibody (Pembrolizumab) for Patients w/Non-Hodgkin Lymphoma | BOSTON SCIENTIFIC CORPORATION | $126,737 | 0 |
| A Single Arm Phase 2 Study of Peri-Operative Ipilimumab, Nivolumab and Cryoablation in Women with Hormone Receptor-Negative, HER2-Negative Early Stage/Resectable Breast Cancer | BOSTON SCIENTIFIC CORPORATION | $111,043 | 0 |
| Cryoablation to improve response to pembrolizumab in metastatic bladder cancer | BOSTON SCIENTIFIC CORPORATION | $15,125 | 0 |
Top Doctors Receiving Payments for Cryoablation
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $252,905 | 9 |
Ad
Manufacturing Companies
- BOSTON SCIENTIFIC CORPORATION $252,905
Product Information
- Type Device
- Total Payments $252,905
- Total Doctors 0
- Transactions 9
About Cryoablation
Cryoablation is a device associated with $252,905 in payments to 0 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is BOSTON SCIENTIFIC CORPORATION.
Payment data is available from 2021 to 2021. In 2021, $252,905 was paid across 9 transactions to 0 doctors.
The most common payment nature for Cryoablation is "Unspecified" ($252,905, 100.0% of total).
Cryoablation is associated with 3 research studies, including "Phase I/II Study of Dendritic Cell Therapy Delivered Intratumorally after Cryoablation & Anti- PD-1 Antibody (Pembrolizumab) for Patients w/Non-Hodgkin Lymphoma" ($126,737).